Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Haubrich

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|June 10, 2017
Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co-encapsulationS H Browne, C Peloquin, F Santillo, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
AIDS (London, England)|May 12, 2000
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levelsB E Sha, V A Johnson, M A Kendall, et al.
Journal of Medicinal Chemistry|August 1, 1987
Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivativesM P Wentland, D M Bailey, E J Alexander, et al.
The Journal of Infectious Diseases|February 11, 2000
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapyH F Günthard, J K Wong, C A Spina, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Pharmacology of pravadoline: a new analgesic agentD R Haubrich, S J Ward, E Baizman, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
AIDS (London, England)|December 28, 2000
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increaseM M Lederman, R McKinnis, D Kelleher, et al.
Antiviral Therapy|August 9, 2001
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adultsD McMahon, M Lederman, D W Haas, et al.
AIDS (London, England)|December 22, 1999
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study TeamR Haubrich, M Thompson, R Schooley, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|June 10, 2017
Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co-encapsulationS H Browne, C Peloquin, F Santillo, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1997
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151M A Fischl, D D Richman, C Flexner, et al.
AIDS (London, England)|May 12, 2000
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levelsB E Sha, V A Johnson, M A Kendall, et al.
Journal of Medicinal Chemistry|August 1, 1987
Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivativesM P Wentland, D M Bailey, E J Alexander, et al.
The Journal of Infectious Diseases|February 11, 2000
Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapyH F Günthard, J K Wong, C A Spina, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Pharmacology of pravadoline: a new analgesic agentD R Haubrich, S J Ward, E Baizman, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
AIDS (London, England)|December 28, 2000
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increaseM M Lederman, R McKinnis, D Kelleher, et al.
Antiviral Therapy|August 9, 2001
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adultsD McMahon, M Lederman, D W Haas, et al.
AIDS (London, England)|December 22, 1999
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study TeamR Haubrich, M Thompson, R Schooley, et al.
Pageof 9